These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21577229)

  • 1. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
    Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
    Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
    Peng BJ; Carlson JM; Liu MKP; Gao F; Goonetilleke N; McMichael AJ; Borrow P; Gilmour J; Heath SL; Hunter E; Bansal A; Goepfert PA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.
    Almeida CA; Bronke C; Roberts SG; McKinnon E; Keane NM; Chopra A; Kadie C; Carlson J; Haas DW; Riddler SA; Haubrich R; Heckerman D; Mallal S; John M
    J Immunol; 2011 Sep; 187(5):2502-13. PubMed ID: 21821798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
    Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
    AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
    Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
    Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
    PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection.
    Qin K; Boppana S; Du VY; Carlson JM; Yue L; Dilernia DA; Hunter E; Mailliard RB; Mallal SA; Bansal A; Goepfert PA
    PLoS Pathog; 2019 Aug; 15(8):e1007970. PubMed ID: 31398241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
    J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
    Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
    AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.